Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

被引:126
作者
Péan, JM
Boury, F
Venier-Julienne, MC
Menei, P
Proust, JE
Benoit, JP
机构
[1] Fac Pharm, UPRES EA 2169, F-49100 Angers, France
[2] CHU Angers, INSERM, U298, F-49033 Angers, France
关键词
NGF; PEG; PLGA; microencapsulation; protein stability; interfacial tension;
D O I
10.1023/A:1014818118224
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The aim of this work was to understand the mechanism by which co-encapsulated PEG 400 improved the stability of NGF and allowed a continuous release from PLGA 37.5/25 microspheres. Methods. Microparticles were prepared according to the double emulsion method. PEG 400 was added with NGF in the internal aqueous phase (PEG/PLGA ratio 1/1 and 1.8/1). Its effect was investigated through interfacial tension studies. Protein stability was assessed by ELISA. Results. A novel application of PEG in protein stabilization during encapsulation was evidenced by adsorption kinetics studies. PEG 400 limited the penetration of NGF in the interfacial film of the primary emulsion. Consequently, it stabilized the NGF by reducing the contact with the organic phase. In addition, it avoided the NGF release profile to level off by limiting the irreversible NGF anchorage in the polymer layers. On the other hand, the amount of active NGF released in the early stages was increased. During microparticle preparation, NaCl could be added in the external aqueous phase to modify the structure of microparticles. This allowed to reduce the initial release rate without affecting the protein stability always encountered in the absence of PEG. Conclusions. PEG 400 appeared of major interest to achieve a continuous delivery of NGF over seven weeks from biodegradable microparticles prepared by the double emulsion technique.
引用
收藏
页码:1294 / 1299
页数:6
相关论文
共 22 条
[1]   ASSOCIATIONS OF BETA-NERVE GROWTH-FACTOR WITH BOVINE SERUM-ALBUMIN AS WELL AS WITH ALPHA-SUBUNITS AND GAMMA-SUBUNITS OF 7S-MACROMOLECULE [J].
ALMON, RR ;
VARON, S .
JOURNAL OF NEUROCHEMISTRY, 1978, 30 (06) :1559-1567
[2]   MECHANISM OF POLY(ETHYLENE GLYCOL) INTERACTION WITH PROTEINS [J].
ARAKAWA, T ;
TIMASHEFF, SN .
BIOCHEMISTRY, 1985, 24 (24) :6756-6762
[3]   Bovine serum albumin release from poly(alpha-hydroxy acid) microspheres: Effects of polymer molecular weight and surface properties [J].
Boury, F ;
Marchais, H ;
Proust, JE ;
Benoit, JP .
JOURNAL OF CONTROLLED RELEASE, 1997, 45 (01) :75-86
[4]   DILATATIONAL PROPERTIES OF ADSORBED POLY(D,L-LACTIDE) AND BOVINE SERUM-ALBUMIN MONOLAYERS AT THE DICHLOROMETHANE/WATER INTERFACE [J].
BOURY, F ;
IVANOVA, T ;
PANAIOTOV, I ;
PROUST, JE ;
BOIS, A ;
RICHOU, J .
LANGMUIR, 1995, 11 (05) :1636-1644
[5]   SUSTAINED-RELEASE OF NERVE GROWTH-FACTOR FROM BIODEGRADABLE POLYMER MICROSPHERES [J].
CAMARATA, PJ ;
SURYANARAYANAN, R ;
TURNER, DA ;
PARKER, RG ;
EBNER, TJ .
NEUROSURGERY, 1992, 30 (03) :313-319
[6]   Characterization of PLGA microspheres for the controlled delivery of IL-1 alpha for tumor immunotherapy [J].
Chen, L ;
Apte, RN ;
Cohen, S .
JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) :261-272
[7]   Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres [J].
Cleland, JL ;
Jones, AJS .
PHARMACEUTICAL RESEARCH, 1996, 13 (10) :1464-1475
[8]  
HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
[9]   THE EFFECT OF PARTICLE MICROSTRUCTURE ON THE SOMATOSTATIN RELEASE FROM POLY(LACTIDE) MICROSPHERES PREPARED BY A W/O/W SOLVENT EVAPORATION METHOD [J].
HERRMANN, J ;
BODMEIER, R .
JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) :63-71
[10]   Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives [J].
Johansen, P ;
Men, Y ;
Audran, R ;
Corradin, G ;
Merkle, HP ;
Gander, B .
PHARMACEUTICAL RESEARCH, 1998, 15 (07) :1103-1110